Cytarabine Iv/Sq/Intrathecal Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 100 mg/mL(IV & SQ); 50 mg/mL(intrathecal use)
Reference Brands: DepoCyt(US)
Category: Blood Disorder
Cytarabine inhibits DNA synthesis by incorporating into DNA strands, disrupting cell replication. It effectively treats leukemia and lymphoma by targeting rapidly dividing cancer cells. Benefits include rapid tumor reduction, improved remission rates, and enhanced survival, making it a key chemotherapeutic agent in hematologic malignancies.
Product Description:
Cytarabine injection is approved in the US by the FDA and in the EU via EMA for treating leukemia and lymphoma. Regulatory approval requires a comprehensive dossier featuring clinical trial data, manufacturing quality, safety, efficacy, and pharmacovigilance plans. In the US, the FDA reviews detailed submissions, while EMA ensures compliance with regional standards. For expert guidance on dossier preparation, regulatory pathways, and successful market entry, visit PharmaTradz. Ensuring regulatory compliance is essential for the safe, effective, and timely approval of cytarabine injection worldwide, supporting optimal patient outcomes and expanded access in oncology treatments.
Cytarabine Iv/Sq/Intrathecal Injection — third party manufacturing & bulk supply
Cytarabine Iv/Sq/Intrathecal Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Cytarabine Iv/Sq/Intrathecal Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Cytarabine Iv/Sq/Intrathecal Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Cytarabine Iv/Sq/Intrathecal Injection →Frequently Asked Questions
Related Products
Daunorubicin Injection
Strength:
20 mg/mL
Form: Intravenous (IV) injection:
Reference Brands: Cerubidine(US)
View Details
Filgrastim Injection (Subcutaneous And Iv)
Strength:
300 million IU
Form: Injection (Subcutaneous and IV)
Reference Brands: Neupogen, Granix, Zarxio(US), Religrast (India)
View Details
Deferasirox Tablets
Strength:
125 mg, 250 mg, and 500 mg
Form: Tablet
Reference Brands: Exjade(Dispersible tablets);Jadenu (Film-coated Tablet)s
View Details
Pegfilgrastim Injection
Strength:
6 mg per single-use syringe
Form: Injection
Reference Brands: Neulasta, Pelgraz(US), Pegex (Inida)
View Details
Quick Response Guaranteed | Verified Suppliers
